CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic derm...
Phase 1
Saint Joseph, Missouri, United States and 13 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
Saint Joseph, Missouri, United States and 23 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Saint Joseph, Missouri, United States and 47 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Overland Park, Kansas, United States and 541 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Leawood, Kansas, United States of America and 555 other locations
Period 2, participants that completed Period 1 will either remain on their assigned dose or be reassigned to a different dose based on their Eczema...
Phase 3
Saint Joseph, Missouri, United States of America and 97 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Overland Park, Kansas, United States and 193 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Shawnee Mission, Kansas, United States and 342 other locations
Clinical trials
Research sites
Resources
Legal